Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

254.28
+5.582.24%
Post-market: 254.280.00000.00%19:52 EDT
Volume:516.75K
Turnover:131.04M
Market Cap:16.51B
PE:17.38
High:255.85
Open:248.75
Low:248.55
Close:248.70
52wk High:265.05
52wk Low:121.40
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.04
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.44
PE(LYR):-43.54

Loading ...

Jazz Pharmaceuticals Plc : Raymond James Raises Target Price to $275 from $239

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals to Report Q2 Financial Results After U.S. Market Close

Reuters
·
Jul 21

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 20

Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals' (JAZZ) Investment Narrative?

Simply Wall St.
·
Jul 20

Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts

TIPRANKS
·
Jul 18

Jazz Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Jazz Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Gain Therapeutics Names Joanne Taylor Chief Scientific Officer, Promotes Terenzio Ignoni to COO

Reuters
·
Jul 16

Jazz Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

Jazz Pharmaceuticals Plc : Barclays Raises Target Price to $260 from $253

THOMSON REUTERS
·
Jul 14

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Jefferies

TIPRANKS
·
Jul 13

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

Jazz Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $270 from $250

THOMSON REUTERS
·
Jul 09

Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist

TIPRANKS
·
Jul 07

Jazz Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Jazz Pharma Director Bruce C. Cozadd Disposes of 6,000 Shares for $1.44 Million

Reuters
·
Jul 07

Jazz Pharmaceuticals Investors Eye Ziihera Launch in GEA as Key Driver, UBS Says

MT Newswires Live
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)

TIPRANKS
·
Jul 01